Product information

Current status:

Cancelled Post Market

Current status date:

2011-02-01

Original market date: ^{See footnote 1}

1992-12-31

Product name:

HEPARIN SODIUM & 5% DEXTROSE INJECTION LIQ

DIN:

02008181 Electronic product monograph is not available

Company:

BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

2

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

20:12.04.16 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B01AB51 HEPARIN, COMBINATIONS

Active ingredient group (AIG) number:^{See footnote5}

0220064003